When Johnson & Johnson acquired Tibotec-Virco in April 2002, he became Company Group Chairman of the Global Virology Franchise at Johnson & Johnson and Chairman of Tibotec.
When Johnson & Johnson acquired Tibotec-Virco in April 2002, he assumed leadership of the company's virology department at Johnson & Johnson and became the head of Tibotec.